ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 440 in its research report dated August 16, 2022.

Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated August 12, 2022.

Hold Glenmark Pharmaceuticals: target of Rs 550: ICICI Direct

ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 550 in its research report dated February 14, 2022.

Accumulate Glenmark Pharmaceuticals target of Rs 575: Geojit

Geojit recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 575 in its research report dated November 18, 2021.

Neutral Glenmark Pharma; target of Rs 560: Motilal Oswal

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 560 in its research report dated November 15, 2021.

Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 600 in its research report dated November 16, 2021.

Neutral Glenmark Pharma; target of Rs 600: Motilal Oswal

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 600 in its research report dated August 16, 2021.

Buy Glenmark Pharmaceuticals; target of Rs 680: ICICI Direct

ICICI Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 680 in its research report dated August 16, 2021.

Glenmark Life Sciences IPO: Traction in complex APIs holds re-rating potential

In order to address the opportunities in oncology, peptides and iron compounds, Glenmark Life Science plans to build an R&D pipeline in the coming years

Buy Glenmark Pharmaceuticals; target of Rs 717: Geojit

Geojit is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 717 in its research report dated June 03, 2021.

Reduce Glenmark Pharmaceuticals target of Rs 509: Prabhudas Lilladher

Prabhudas Lilladher recommended reduce rating on Glenmark Pharmaceuticals with a target price of Rs 509 in its research report dated Jun 01, 2021.

Neutral Glenmark Pharma; target of Rs 580: Motilal Oswal

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 580 in its research report dated May 31, 2021.

Buy Glenmark Pharmaceuticals; target of Rs 635: ICICI Direct

ICICI Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 635 in its research report dated February 15, 2021.

Buy Glenmark Pharmaceuticals: target of Rs 635: ICICI Direct

ICICI Direct is bullish on Glenmark Pharmaceuticals recommended buy rating on the stock with a target price of Rs 635 in its research report dated November 09, 2020.

Quant Pick - Glenmark Pharma: ICICI Direct

According to ICICI Direct, The pharma space has shown significant resilience in the last couple of weeks amid broader market volatility.

Buy Glenmark Pharma; target of Rs 576 KRChoksey

KRChoksey is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 576 in its research report dated August 20, 2020.

Buy Glenmark Pharma; target of Rs 575: Emkay Global Financial

Emkay Global Financial is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 575 in its research report dated August 17, 2020.

Neutral Glenmark Pharma; target of Rs 495: Motilal Oswal

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 495 in its research report dated August 17, 2020.

Sell Glenmark Pharmaceuticals; target of Rs 365: Prabhudas Lilladher

Prabhudas Lilladher is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 365 in its research report dated August 18, 2020.

Buy Glenmark Pharmaceuticals; target of Rs 560: ICICI Direct

ICICI Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 560 in its research report dated August 17, 2020.

Sell Glenmark Pharmaceuticals; target of Rs 365: Prabhudas Lilladher

Prabhudas Lilladher is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 365 in its research report dated June 29, 2020.

Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 430 in its research report dated June 29, 2020.

Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial

Emkay Global Financial is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 526 in its research report dated June 29, 2020.

Buy Glenmark Pharma; target of Rs 488: ICICI Securities

ICICI Securities is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 488 in its research report dated June 22, 2020.

Sell Glenmark Pharmaceuticals; target of Rs 257: Prabhudas Lilladher

Prabhudas Lilladher is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 257 in its research report dated June 23, 2020.